. Quick takes: New SARS-CoV-2 lab leak assessment, claims for ivermectin benefit beyond COVID - IOPAC Press "Enter" to skip to content

Rafah incursion would substantially increase mortality and morbidity and further weaken an already broken health system
- All WHO news
WHO is deeply concerned that a full-scale military operation in Rafah could lead to a bloodbath. More than 1.2 million...
Governments near agreement on package of amendments to the International Health Regulations (2005)
- All WHO news
In the eighth meeting of the Working Group on Amendments to the International Health Regulations (WGIHR), which was suspended yesterday...
WHO and France convene high-level meeting to defeat meningitis
- All WHO news
<p>Global<strong> </strong>leaders highlight the need to defeat meningitis – a leading cause of disability – at a high-level meeting co-hosted...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Quick takes: New SARS-CoV-2 lab leak assessment, claims for ivermectin benefit beyond COVID

By iopac on February 28, 2023

The Department of Energy, with “low confidence,” says SARS-CoV-2 may have come from a lab, and a controversial doctors groups touts ivermectin for the flu and RSV.

Published in COVID-19

iopac

More from COVID-19More posts in COVID-19 »